Immunovia publishes link to Webinar No. 3 on IMMray™ PanCan-d: Verification Study and Clinical Use
LUND, SWEDEN – Immunovia AB (publ) (”Immunovia”) today published the link to the company’s third webinar in a series on IMMray™ PanCan-d, Immunovia´s test for early detection of pancreatic cancer. The webinar will cover the IMMray™ PanCan-d verification study results and its clinical use, including feedback from experts in pancreatic cancer and pancreatic diseases. Event Details: Webinar No. 3 in Immunovia’s IMMray™ PanCan-d Webinar Series: Verification Study and Clinical Use Date and Time: December 17, 2020 at 15:00 CET Moderator for the webinar: CEO Patrik Dahlen Presenters: